Incobotulinumtoxina – November 2024

• Brand names:
  • Xeomin®
• Pharmaceutical Company:
  • MERZ AUSTRALIA PTY LTD
• Condition/Indication: Chronic sialorrhea
• Meeting Date: November 2024
• Public Summary Document (PSD) November 2024 May 2025 PBAC Meetings - (PDF 1.1MB)
• Public Summary Document (PSD) November 2024 May 2025 PBAC Meetings - (Word 513KB)

Related Public Summary Documents

• IncobotulinumtoxinA – May 2025